This protocol covers posterior uveitis in the context of punctate inner choroidopathy (PIC) where neither a choroidal neovascular membrane (CNVM) nor subretinal fibrosis is present — a distinct subgroup that requires its own management pathway.
Punctate inner choroidopathy without CNVM or subretinal fibrosis defines patients at an earlier or less complicated stage of the condition. Complications such as CNVM and subretinal fibrosis can emerge, particularly within the first year, making the current status of these features central to clinical decision-making.
For this specific presentation, the evidence-based protocol defines what is — and is not — typically indicated for the majority of patients. The complete structured regimen, including the recommended pathway and any follow-up considerations, is available via the link below.
DOI: 10.4103/0301-4738.58470
No treatment is advised for the majority of patients without CNVM or subretinal fibrosis, which usually occurs within the first year.
View source ↗